DePuy hip implant recall – August 2010

Leading health care manufacturer Johnson&Johnson has felt the pressure after the DePuy ASR hip implant recall last year. According to Newsinferno and The Wall Street Journal blog Johnson&Johnson’s forth quarter profit fell 12%, the equivalent to a $922 million drop. This far exceeded analysts’ expectations and has attracted global attention from the financial media sector. Although the DePuy hip implant recall has been the focus of much attention, the company has come under scrutiny for other such quality control recalls; namely, Tylenol, Motrin and Benadryl. Shares of the company took a downturn decreasing from 79 cents a share to 70 cents a share in the period 2009-2010. In larger monetary terms, this is the equivalent of net income dropping from $2.21 billion to $1.94 billion. This drop in income was not unrelated to the multiple recalls, as global consumers were deterred from buying Johnson&Johnson products resulting in a consumer-product sale drop of 15%. Moreover, the company is currently facing a DePuy lawsuit flurry that can damage its financial state as well.

A global recall for the ASR XL DePuy hip implant was issued in August 2010. Since then data from the National Joint Registry of England and Wales has suggested that 12-13% of individuals fitted with DePuy hip implant had to go a second round of surgery within 5 years. Within this five year period, more than 93,000 patients were fitted with the implant – and it has been indicated that around 35% of the individuals fitted were in the United States. Complaints from persons who have received the implant have included loose hip cups, permanent tissue and muscle damage, bone fractures and tumours as a consequence of the metal. DePuy hip implant pain has been the source of much controversy. However, if you have suffered at the hands of Johnson&Johnson you may be entitled to take legal action. Contact a qualified personal injury attorney at our firm today for a free consultation on your DePuy hip lawsuit.

An increase in earnings of 1-3% has been predicted; however, the company’s finances are in flux with medical device and drug recalls attracting significant worldwide attention, with future product recalls not ruled out. Would you feel safe using Johnson&Johnson products? DePuy hip implant inflammation is no joking matter; terrible pain can result in limited physical mobility an, as a result, loss of earnings. If you would like to discuss your experience with one of our personal injury lawyers, please get in touch as soon as possible!